WVE - Wave Life Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$18.00
LOW:
$12.00
MEDIAN:
$13.00
CONSENSUS:
$14.00
UPSIDE:
187.47%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,772,228 | $10.3M | 0.0% | +1,699,923 | INCREASED |
| Druckenmiller | 173,000 | $1.0M | 0.0% | -- | UNCHANGED |
| Wood | 2,800 | $16,268 | -- | -33,800 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-11 | Wagner Heidi L | director | SELL | 7,000 | $6.01 | $42K |
| 2026-08-11 | Wagner Heidi L | director | M-Exempt | 7,000 | $5.97 | $42K |
| 2026-08-12 | Rawcliffe Adrian | director | SELL | 12,700 | $5.29 | $67K |
| 2026-08-11 | TAKANASHI KEN | director | SELL | 3,864 | $6.01 | $23K |
| 2026-08-11 | Tan Aik Na | director | SELL | 432 | $6.01 | $3K |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | 350,000 | $5.85 | $2.0M |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | 200,000 | $11.74 | $2.3M |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | 273,750 | $12.75 | $3.5M |
| 2026-04-09 | Wright Christopher I | officer: Chief Medical Officer | ? | -- | -- | -- |
| 2026-04-09 | Wright Christopher I | officer: Chief Medical Officer | ? | 273,750 | $12.75 | $3.5M |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | -- | -- | -- |
| 2026-04-09 | Wright Christopher I | officer: Chief Medical Officer | ? | 300,000 | $5.94 | $1.8M |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 971,091 | $6.50 | $6.3M |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 2,495,623 | $6.43 | $16.0M |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 4,954,558 | $6.06 | $30.0M |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 351,224 | $6.38 | $2.2M |
| 2026-03-23 | TAKANASHI KEN | director | C-Conversion | 3,901,348 | -- | -- |
| 2026-02-26 | Francis Chris | officer: See Remarks | M-Exempt | 15,294 | $4.75 | $73K |
| 2026-02-26 | Francis Chris | officer: See Remarks | M-Exempt | 17,900 | $3.87 | $69K |
| 2026-02-26 | Francis Chris | officer: See Remarks | SELL | 15,294 | $15.00 | $229K |
| 2026-02-26 | Francis Chris | officer: See Remarks | SELL | 17,900 | $15.09 | $270K |
| 2026-02-05 | Moran Kyle | officer: Chief Financial Officer | A-Award | 273,750 | $12.75 | $3.5M |
| 2026-02-05 | Francis Chris | officer: See Remarks | A-Award | 38,750 | -- | -- |
| 2026-02-09 | Francis Chris | officer: See Remarks | SELL | 1,883 | $13.45 | $25K |
| 2026-02-05 | Vargeese Chandra | officer: See Remarks | A-Award | 273,750 | $12.75 | $3.5M |